Table 2 Clinical outcomes according to the presence of hypertension
From: Hypertension, renin-angiotensin-aldosterone-system-blocking agents, and COVID-19
Clinical outcome | Total (n = 3,788) | Hypertension (n = 1,190) | Non-hypertension (n = 2,598) | Unadjusted | Age, sex-adjusted | Multivariable adjusted | |||
|---|---|---|---|---|---|---|---|---|---|
OR (95 % CI) | P-value | OR (95 % CI) | P-value | OR (95 % CI) | P-value | ||||
Hospitalization | 1,481 (39.1) | 587 (49.3) | 894 (34.4) | 1.86 (1.61‒2.13) | < 0.001 | 0.96 (0.81‒1.14) | 0.634 | 1.15 (0.95‒1.38) | 0.146 |
Oxygen requirement | 267 (7.0) | 154 (12.9) | 113 (4.3) | 3.27 (2.54‒4.21) | < 0.001 | 1.24 (0.92‒1.68) | 0.159 | 1.33 (0.96‒1.83) | 0.083 |
Severe outcome | 123 (3.2) | 85 (7.1) | 38 (1.5) | 5.18 (3.51‒7.65) | < 0.001 | 1.66 (1.06‒2.59) | 0.026 | 1.67 (1.04‒2.69) | 0.034 |
ICU admission | 55 (1.5) | 38 (3.2) | 17 (0.7) | 5.01 (2.82‒8.91) | < 0.001 | 2.59 (1.33‒5.05) | 0.005 | 2.69 (1.33‒5.43) | 0.006 |
Ventilator care | 34 (0.9) | 25 (2.1) | 9 (0.3) | 6.17 (2.87‒13.3) | < 0.001 | 2.50 (1.05‒5.94) | 0.038 | 2.85 (1.18‒6.92) | 0.020 |
Death | 83 (2.2) | 61 (5.1) | 22 (0.8) | 6.32 (3.87‒10.3) | < 0.001 | 1.36 (0.78‒2.36) | 0.274 | 1.24 (0.69‒2.25) | 0.473 |